These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9123169)

  • 1. Severe cyclosporine arteriolopathy with focal segmental glomerulosclerosis is not a fatal finding in chronic renal allograft failure after year 5 of transplantation using cyclosporine.
    Takeda A; Morozumi K; Koyama K; Yoshida A; Uchida K; Tominaga Y; Haba T; Oikawa T; Usami T; Sugito K; Takeuchi O; Fujinami T; Yokoyama I; Takagi H
    Transplant Proc; 1997; 29(1-2):96-9. PubMed ID: 9123169
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic and nonimmunologic contributors to glomerular segmental sclerosis in renal transplantation.
    Jeong HJ; Kim YS; Oh CK; Park K; Choi IJ
    Transplant Proc; 1996 Jun; 28(3):1224-5. PubMed ID: 8658635
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of cyclosporine-associated arteriolopathy in renal transplantation: does the long-term outcome of renal allografts depend on chronic cyclosporine nephrotoxicity?
    Takeda A; Morozumi K; Yoshida A; Uchida K; Tominaga Y; Fujinami T; Yokoyama I; Takagi H
    Transplant Proc; 1994 Apr; 26(2):925-8. PubMed ID: 8171705
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term effects of chronic cyclosporine nephropathy on outcome of renal allografts.
    Takeda A; Morozumi K; Haba T; Katayama A; Tominaga Y; Uchida K
    Transplant Proc; 2001; 33(7-8):3379-80. PubMed ID: 11750445
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic cyclosporine nephropathy in renal transplantation.
    Bennett WM; DeMattos A; Meyer MM; Andoh T; Barry JM
    Transplant Proc; 1996 Aug; 28(4):2100-3. PubMed ID: 8769166
    [No Abstract]   [Full Text] [Related]  

  • 6. Is cyclosporine-associated glomerulopathy a new glomerular lesion in renal allografts using CyA?
    Takeda A; Morozumi K; Uchida K; Yokoyama I; Takagi H; Yoshida A; Fujinami T; Thiel G; Gudat F; Mihatsch MJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):515-7. PubMed ID: 8438396
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
    Turner CD; Bruce DS; Cronin DC; Loss GE; Grewal H; Siegel C; Millis JM; Newell KA; Davis B; Todo T; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1998 Jun; 30(4):1234-5. PubMed ID: 9636501
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
    Höcker B; Knüppel T; Waldherr R; Schaefer F; Weber S; Tönshoff B
    Pediatr Nephrol; 2006 Oct; 21(10):1476-9. PubMed ID: 16721582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cyclosporin nephropathy: long-term effects of cyclosporin on renal allografts.
    Takeda A; Uchida K; Haba T; Tominaga Y; Katayama A; Yoshida A; Oikawa T; Morozumi K
    Clin Transplant; 2001; 15 Suppl 5():22-9. PubMed ID: 11791791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts.
    Morozumi K; Thiel G; Gudat F; Mihatsch MJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):537-9. PubMed ID: 8438404
    [No Abstract]   [Full Text] [Related]  

  • 11. Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
    Yilmaz S; Taskinen E; Häyry P; Isoniemi H
    Transplant Proc; 1996 Feb; 28(1):491-3. PubMed ID: 8644324
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopathological evaluation in non-episode biopsies of renal transplant allograft.
    Toki K; Kyo M; Takahara S; Hatori M; Morozumi K; Ichimaru N; Tanaka T; Wang JD; Permpongkosol S; Miyamoto M; Oka K; Imai E; Kyakuno M; Nakamura T; Kojima Y; Inoue T; Kameoka H; Ding XQ; Kokado Y; Okuyama A
    Transpl Int; 2000; 13 Suppl 1():S73-7. PubMed ID: 11111966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival.
    Cosio FG; Frankel WL; Pelletier RP; Pesavento TE; Henry ML; Ferguson RM
    Am J Kidney Dis; 1999 Oct; 34(4):731-8. PubMed ID: 10516356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
    Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
    Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of cyclosporine-associated arteriolopathy in renal transplant biopsies from 1981 to 1992.
    Strøm EH; Thiel G; Mihatsch MJ
    Transplant Proc; 1994 Oct; 26(5):2585-7. PubMed ID: 7940802
    [No Abstract]   [Full Text] [Related]  

  • 17. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.
    Randhawa PS; Shapiro R; Jordan ML; Starzl TE; Demetris AJ
    Am J Surg Pathol; 1993 Jan; 17(1):60-8. PubMed ID: 7680544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transplantation and cyclosporine nephrotoxicity.
    Ahmed SB; Waikar SS; Rennke HG; Singh AK
    Kidney Int; 2007 Oct; 72(8):1029-33. PubMed ID: 17507904
    [No Abstract]   [Full Text] [Related]  

  • 19. Relative contribution of HLA disparity to chronic allograft nephropathy.
    Baltzan MA; Shoker AS; Baltzan MA
    Transplant Proc; 2002 Dec; 34(8):3125-7. PubMed ID: 12493395
    [No Abstract]   [Full Text] [Related]  

  • 20. Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report.
    Nowacka-Cieciura E; Perkowska-Ptasińska A; Sulikowska-Rowińska A; Cieciura T; Wazna E; Durlik M
    Transplant Proc; 2009; 41(1):441-5. PubMed ID: 19249576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.